SUNPHARMA vs TRENT: Stock Comparison
SUN PHARMACEUTICAL IND L is the larger company by market capitalisation. SUN PHARMACEUTICAL IND L shows a lower P/E, a higher dividend yield and lower leverage, while TRENT shows a higher ROE, faster revenue growth and a higher ROCE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
SUNPHARMA leads 7; TRENT leads 4 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | SUNPHARMA | TRENT |
|---|---|---|
| Sector | Healthcare | Consumer Services |
| Industry | Pharmaceuticals | Speciality Retail |
Price
| Metric | SUNPHARMA | TRENT |
|---|---|---|
| Live Price | ₹1,745.3 | ₹2,705.7 |
| Day Change | -0.72% | -2.53% |
| Volume | 7.02 L | 5.37 L |
| 52-Week High | ₹2,046.9 | ₹4,866.5 |
| 52-Week Low | ₹1,583.7 | ₹2,545.8 |
| Distance from 52W High | -14.73% | -44.4% |
Valuation
| Metric | SUNPHARMA | TRENT |
|---|---|---|
| Market Cap | ₹4.19 L Cr | ₹1.44 L Cr |
| P/E Ratio | 34.79x | 81.81x |
| P/B Ratio | 5.04x | 21.18x |
| EPS | ₹50.77 | ₹9.73 |
| Book Value | ₹348.31 | ₹133.3 |
| Dividend Yield | 0.92% | 0.14% |
Growth
| Metric | SUNPHARMA | TRENT |
|---|---|---|
| Revenue Growth (TTM YoY) | 12.8% | 19.2% |
| EPS Growth (TTM YoY) | 25.6% | 25.8% |
| Qtr Sales Growth | 0% | 0% |
| Qtr Profit Growth | 0% | 0% |
Profitability & Leverage
| Metric | SUNPHARMA | TRENT |
|---|---|---|
| ROE | 13.72% | 25.55% |
| ROCE | 15.12% | 26.59% |
| Net Margin | 18.56% | 8.57% |
| Operating Margin | 26.44% | 13.58% |
| Debt to Equity | 0.05x | 0.06x |
Shareholding
As of Sep 2026 • change vs previous quarter| Metric | SUNPHARMA | TRENT |
|---|---|---|
| Promoter Holding | 52.68%▼ 1.8 pp | 37.01% |
| FII Holding | 14.36%▼ 0.17 pp | 15.28%▲ 0.14 pp |
| DII Holding | 22.27%▲ 0.09 pp | 23.33%▲ 0.06 pp |
| Public Holding | 10.7%▲ 1.89 pp | 24.38%▼ 0.19 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: SUN PHARMACEUTICAL IND L and TRENT.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.